Perivascular epithelial remodeling is reflected in circulating cfDNA methylation signals as detection markers for early esophageal tumorigenesis
A blood test using 11 genes can detect early esophageal cancer and precancerous lesions in community screening with reasonable accuracy, potentially catching disease when treatment works best.
Researchers developed an 11-gene blood-based methylation panel to detect high-grade precancerous lesions and early esophageal cancer. In prospective community screening it achieved 78% sensitivity at 79% specificity, with supportive results in independent case-control cohorts.
What the study was
- Study design
- Prospective community screening study with multi-cohort validation
- Population
- Community screening participants and retrospective case-control cohorts for esophageal neoplasia
- Category
- Early Detection
- Maturity
- Validated
- Journal
- Cancer discovery
Why it surfaced
Direct prospective cancer-screening evidence with reported sensitivity and specificity supports a high early-detection priority.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.